Aprea Therapeutics (APRE) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.42
-1.17
-0.92
-0.67

Details

Expected EPS
-0.76
Actual EPS
-0.67
Surprise EPS
0.09
Surprise Percent
+11.84%

Description

Aprea Therapeutics (APRE) has reported earnings of -0.67 per share for Q2 2024.

0 Comments

Share your thoughts